Faron Pharmaceuticals Investor Relations Material
Latest events
H2 2023
Faron Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Faron Pharmaceuticals
Access all reports
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. It focuses on the discovery and development of anti-scarring drugs, immunotherapy treatments, and cancer vaccines. The company’s product pipeline includes Traumakine, which is used in the treatment of acute respiratory distress syndrome; Clevegen that targets the programmed cell death 1/programmed cell death ligand 1 pathway involved in tumor growth and suppression; and preclinical stage product candidates, such as Apograft for the treatment of solid tumors. Faron Pharmaceuticals Oy was founded in 2000 and is headquartered in Turku, Finland.
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇫🇮 Finland